2017-03-19,Here's a Look at the 64 Best Performing Stocks Over the Last 4 Months
2017-03-15,After Soaring to $150, Can Incyte Stir Up More Upside?
2017-03-13,Incyte Corporation Stock Rises on Price Target Increase
2017-03-10,Incyte Pops on Continued Gilead Takeout Speculation
2017-03-10,Incyte Likely to Incite Further Gains
2017-03-10,Don't Give the Fed Credit for This Bull: Cramer's 'Mad Money' Recap (Thursday 3/9/17)
2017-03-09,Cramer: Don't Give the Fed Credit
2017-03-02,Incyte's Targeted Therapy And Immuno-oncology Portfolio To Be Featured In 20 Abstracts At The AACR Annual Meeting 2017
2017-02-28,Voices Of MPN Heroes Video
2017-02-27,Cramer: Money's Being Thrown at Almost Everything in the Market
2017-02-27,Cramer: Money's Being Thrown at Almost Everything in the Market
2017-02-24,4 Biotech Stocks on the Move
2017-02-24,Biotech Movers: Cempra Flys High On Phase Three Results
2017-02-23,Incyte Announces Oncology Research Alliance With The Abramson Cancer Center At The University Of Pennsylvania
2017-02-23,Incyte, Skyworks Solutions, Western Digital, Constellation Brands: 'Mad Money' Lightning Round
2017-02-23,What You Should Do if This Market Is Overvalued: Cramer's 'Mad Money' Recap (Wednesday 2/22/17)
2017-02-21,Incyte To Present At Upcoming Investor Conferences
2017-02-15,Additional Results From Pivotal RA-BEAM Study Published In New England Journal Of Medicine Show Baricitinib-treated Patients Demonstrated Sustained Improvement In Rheumatoid Arthritis Compared To Adalimumab And Placebo
2017-02-15,Softness in Incyte Should Be Short-Lived, if Our Quants Are Right
2017-02-15,Ratings Changes Today
2017-02-14,Http://www.agenusbio.com
2017-02-14,Incyte Reports 2016 Fourth-Quarter And Year-End Financial Results, Provides 2017 Financial Guidance And Updates On Key Clinical Programs
2017-02-14,5 Things You Must Know Before the Market Opens Tuesday
2017-02-12,Week Ahead: Federal Reserve Officials, Major Economic Data to Drive Market Movement
2017-01-30,Incyte And Calithera Biosciences Announce Global Collaboration To Develop And Commercialize CB-1158, A First-in-class, Small Molecule Arginase Inhibitor
2017-01-24,Incyte To Report Fourth Quarter And Year-End Financial Results
2017-01-10,4 Biotech Names That Could Be M&amp;A Targets
2017-01-09,Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference
2017-01-09,Merck Cancer Drug Test Sends Incyte Shares Higher
2017-01-09,Biotech Stocks Surge Monday Amid Flurry of Deal Activity
2017-01-09,Incyte And Merck To Advance Clinical Development Program Investigating The Combination Of Epacadostat With KEYTRUDA® (pembrolizumab)
2017-01-05,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
2017-01-03,Biotech Should Witness M&amp;A's Return in 2017
2016-12-30,Incyte Announces First Patient Treated In Pivotal Clinical Trial Program For Ruxolitinib (Jakafi®) In Graft-versus-Host Disease
2016-12-21,Incyte And Merus Announce Global Strategic Research Collaboration To Discover And Develop Bispecific Antibodies
2016-12-13,Incyte To Present At Upcoming Investor Conference
2016-12-04,Pooled Analysis Of Five-Year Data From Two Phase 3 Studies Further Supports Overall Survival Advantage Observed In Patients With Myelofibrosis Treated With Jakafi® (ruxolitinib)
2016-11-18,2 Small-Cap Biotech Buyout Targets
2016-11-17,Get Excited About Incyte
2016-11-17,Hey Gilead, Stop Developing Drugs and Start Buying Biotech Companies -- Now!
2016-11-14,Baricitinib Demonstrates Early Response Compared To Placebo And Significant Improvement Compared To Adalimumab In Patient-Reported Outcomes
2016-11-13,Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
2016-11-10,Incyte Becomes #40 Most Shorted Nasdaq 100 Component, Replacing Stericycle
2016-11-08,Gilead Sciences' Next Challenge to Incyte's Myelofibrosis Drug Dominance
2016-11-03,More Than 20 Abstracts Highlighting Data From Incyte's Portfolio Accepted For Presentation At The 58th Annual ASH Meeting
2016-11-02,Why Incyte's Shares Could Soon Hit $100
2016-11-02,Incyte To Present At Upcoming Investor Conference
2016-11-01,Incyte Reports 2016 Third-Quarter Financial Results And Updates Key Clinical Programs
2016-11-01,There's Still Time to Buy These 5 Breakout Trades
2016-10-14,Incyte To Report Third Quarter Financial Results
2016-10-07,Additional Phase 1 Data From ECHO-202 Reinforce Durability Of Response In Patients With Treatment-naive Advanced Or Metastatic Melanoma Treated With Epacadostat In Combination With Keytruda® (pembrolizumab)
2016-09-28,Updated Phase 1 Data Reinforce The Clinical Profile Of Epacadostat In Combination With Keytruda® (Pembrolizumab)
2016-09-27,The New #42 Most Shorted Nasdaq 100 Component: Incyte
2016-09-27,NCCN Guidelines® Recommend Jakafi® (ruxolitinib) For The Treatment Of Myelofibrosis
2016-09-22,New Setback for Sanofi's Lantus Increases Need for M&amp;A
2016-09-08,Incyte Supports Those Affected By Rare Blood Cancers On MPN Awareness Day And Throughout Blood Cancer Awareness Month
2016-09-01,'Mad Money' Lightning Round: I'm Staying With Potash
2016-08-31,Jim Cramer's 'Mad Money' Recap: Oil Regains Control of the Stock Market
2016-08-30,Incyte To Present At Upcoming Investor Conferences
2016-08-25,Forbes Magazine Names Incyte To Its List Of World's Most Innovative Companies For Second Consecutive Year
2016-08-22,Incyte (INCY) Stock Rises on Takeover Speculation After $14 Billion Pfizer, Medivation Deal
2016-08-10,How Will Incyte (INCY) Stock React to Price Target Raise at Barclays?
2016-08-09,Why There Is Upside for Incyte Despite Recent Selloff
2016-08-09,Today's Roof Leaker Stock Is Incyte (INCY)
2016-08-09,Incyte Reports 2016 Second-Quarter Financial Results And Updates Key Clinical Programs
2016-08-03,Insider Trading Alert - CFFI, KERX And INCY Traded By Insiders
2016-08-01,Could a Spin-off of its Hepatitis C Division be in Gilead's Future?
2016-07-27,The New #38 Most Shorted Nasdaq 100 Component: Incyte
2016-07-22,3 Stocks Dragging In The Drugs Industry
2016-07-19,Updated Data For Epacadostat, Incyte's Selective IDO1 Inhibitor, Accepted For Presentation At The ESMO Annual Congress 2016
2016-07-14,Incyte To Report Second Quarter Financial Results
2016-07-13,3 Stocks Pushing The Health Care Sector Lower
2016-07-01,Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-23,FDA Grants Breakthrough Therapy Designation For Incyte's Ruxolitinib (Jakafi®) In Acute Graft-Versus-Host Disease (GVHD)
2016-06-22,Incyte Announces First Patient Treated In ECHO-301 Phase 3 Study
2016-06-10,New Phase 3 Data Show Jakafi® (ruxolitinib) Is Superior To Best Available Therapy In Patients With Polycythemia Vera (PV)
2016-06-06,Five-year Results From Phase 3 Study Of Jakafi® (ruxolitinib) Show Sustained Overall Survival Benefit In Patients With Myelofibrosis (MF)
2016-06-01,Incyte And Moffitt Cancer Center Establish Multi-Year Oncology Research Alliance
2016-05-31,Incyte Announces The Launch Of The Incyte Charitable Giving Foundation
2016-05-31,3 Health Care Stocks Pushing Sector Growth
2016-05-26,Investors Eager for Gilead to Make Big Moves
2016-05-25,Gilead (GILD) Shares Spike After Executive Board Appointment
2016-05-19,Incyte Highlights Jakafi® (ruxolitinib) And Capmatinib Abstracts To Be Presented At The 2016 ASCO And EHA Annual Meetings
2016-05-18,Incyte To Present At Upcoming Investor Conferences
2016-05-09,Incyte Buys European Business Hub From Ariad Pharma
2016-05-09,Incyte First Quarter Financial Results Conference Call And Webcast
2016-05-09,Incyte Reports 2016 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs
2016-05-03,The New #44 Most Shorted Nasdaq 100 Component: Incyte
2016-04-28,Incyte To Present At Upcoming Investor Conferences
2016-04-18,Incyte (INCY) Weak On High Volume
2016-04-15,Incyte Investor Event At AACR 2016 To Highlight Innovative And Diversified Research And Development Portfolio
2016-04-14,Incyte To Report First Quarter Financial Results
2016-04-06,Incyte Acquires Rights From Lilly To Develop And Commercialize Ruxolitinib (Jakafi®) For The Treatment Of Patients With Graft-Versus-Host Disease (GVHD)
2016-03-31,Jim Cramer's 'Mad Money' Recap: Good Riddance to a Roller-Coaster Quarter
2016-03-31,Strong On High Relative Volume: Incyte (INCY)
2016-03-31,Phase 3 Study Findings Demonstrate Treatment With Baricitinib Results In Significant Improvements For Patients With Rheumatoid Arthritis Who Had Inadequate Response To Biologics
2016-03-26,5 Stocks Insiders Love Right Now
2016-03-16,Incyte's Immuno-oncology And Targeted Therapy Portfolio To Be Featured At The AACR Annual Meeting 2016
2016-03-09,BMRN, INCY And ALXN, Pushing Drugs Industry Downward
2016-03-02,5 Stocks Insiders Have Been Scooping Up Lately
2016-02-29,Voices Of MPN Rare Disease Day Video
2016-02-20,Jim Jubak&rsquo;s Four Favorite Stocks for Turbulent Markets
2016-02-20,Jim Jubak’s Four Favorite Stocks for Volatile Times
2016-02-17,Ratings Changes Today
2016-02-16,Incyte To Present At Upcoming Investor Conferences
2016-02-12,Incyte (INCY) Stock Price Target Lowered at Jefferies
2016-02-11,Here's Why Incyte (INCY) Stock is Tanking Today
2016-02-11,Unusual Social Activity Today Around Incyte (INCY)
2016-02-11,Incyte Falls on Jakafi Solid-Tumor Setback
2016-02-11,Incyte Reports 2015 Fourth-Quarter And Year-End Financial Results, Provides 2016 Financial Guidance And Updates Shareholders On Key Clinical Programs
2016-02-11,Incyte Announces Decision To Discontinue JANUS Studies Of Ruxolitinib Plus Capecitabine In Patients With Advanced Or Metastatic Pancreatic Cancer
2016-02-05,Incyte (INCY): Today's Weak On High Volume Stock
2016-01-27,Post-Market Activity Shows Incyte (INCY) Down
2016-01-27,Incyte Announces Decision To Stop Phase 2 Sub-study Of Ruxolitinib Plus Regorafenib In Patients With Metastatic Colorectal Cancer And High CRP
2016-01-25,Strong On High Relative Volume: Incyte (INCY)
2016-01-21,Incyte To Report Fourth Quarter/Year-End Financial Results
2016-01-19,Lilly And Incyte Announce Submission Of New Drug Application To FDA For Oral Once-Daily Baricitinib For Treatment Of Moderate-to-Severe Rheumatoid Arthritis
2016-01-12,Incyte (INCY) Shows Signs Of Being Water-Logged And Getting Wetter
2016-01-12,3 Stocks Pulling The Drugs Industry Downward
2016-01-11,Incyte Presents Significant Progress In Its Development Portfolio
2016-01-11,Incyte And AstraZeneca Announce New Lung Cancer Clinical Trial Collaboration
2016-01-07,Trade-Ideas: Incyte (INCY) Is Today's Weak On High Relative Volume Stock
2016-01-07,Jim Cramer's Top Takeaways: Starbucks, Alphabet, Ulta Salon, Micron, Viacom
2016-01-06,Jim Cramer's 'Mad Money' Recap: Good Things to Remember Amid the Fallout
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-26,Sell These 6 Biotech Stocks Now Before It's Too Late
2015-12-24,4 Great Stock-ing Stuffers for 2016
2015-12-22,NVO, INCY And ILMN, Pushing Drugs Industry Downward
2015-12-14,Incyte To Present At The 34th Annual J. P. Morgan Healthcare Conference
2015-12-05,Two Phase 3 Studies Reinforce Sustained Benefits Of Treatment With Jakafi® (ruxolitinib) In Patients With Myeloproliferative Neoplasms (MPNs)
2015-12-05,Phase 3 RESPONSE-2 Study Of Jakafi® (ruxolitinib) Meets Primary Endpoint
2015-12-01,3 Stocks Dragging The Drugs Industry Downward
2015-11-30,Incyte's Jakafi® (ruxolitinib) To Be Featured In Over 60 Abstracts At ASH Annual Meeting
2015-11-18,Goldman Sees Bluebird Shares Doubling On 'One-Shot' Gene Therapy
2015-11-13,Bearish Bets: Personal Bear Market Continues for Energy Stocks
2015-11-09,3 Drugs Stocks Driving The Industry Higher
2015-11-09,Incyte (INCY) Showing Signs Of A Dead Cat Bounce Today
2015-11-07,Detailed Results Demonstrate Baricitinib Superiority To Adalimumab In Improving Signs And Symptoms Of Rheumatoid Arthritis
2015-11-06,Incyte (INCY) Is Today's Roof Leaker Stock
2015-11-06,Ratings Changes Today
2015-11-04,Retrophin Sinks, Pharma Group Swings Back As Pricing Fight Escalates
2015-11-03,Weak On High Volume: Incyte (INCY)
2015-11-03,Epacadostat In Combination With Pembrolizumab Demonstrates Promising Clinical Activity In Multiple Advanced Cancers
2015-11-03,Incyte Reports 2015 Third-Quarter Financial Results And Updates Shareholders On Key Clinical Programs
2015-10-22,Northwest Bio Bothers British Bestie for Bounteous Bucks
2015-10-16,3 Stocks Dragging The Health Care Sector Downward
2015-10-16,Trade-Ideas: Incyte (INCY) Is Today's "Perilous Reversal" Stock
2015-10-13,Incyte To Report Third Quarter Financial Results
2015-10-13,Incyte And Merck Expand Clinical Collaboration To Include Phase 3 Study Investigating The Combination Of Epacadostat With Keytruda® (pembrolizumab) As First-line Treatment For Advanced Melanoma
2015-10-05,Incyte (INCY) Highlighted As Today's Perilous Reversal Stock
2015-10-02,Data At SITC Annual Meeting To Highlight Progress Of Incyte's Immuno-oncology Portfolio
2015-09-30,10 Best Nasdaq Biotech Stocks in the Third Quarter
2015-09-30,Strong On High Relative Volume: Incyte (INCY)
2015-09-29,Market News: Under Armour, OvaScience, Incyte Corporation
2015-09-29,Incyte (INCY) Stock Climbs on Positive Arthritis Test Results
2015-09-29,Eli Lilly (LLY) Stock Climbs on Positive Arthritis Drug Test Results
2015-09-29,Incyte (INCY) Weak On High Volume
2015-09-28,Trade-Ideas: Incyte (INCY) Is Today's "Roof Leaker" Stock
2015-09-16,Insider Trading Alert - RP, LAYN And INCY Traded By Insiders
2015-09-15,Incyte To Present At The Leerink Partners Inaugural Immuno-Oncology Roundtable Conference
2015-09-14,Incyte (INCY) In A Perilous Reversal
2015-09-03,Incyte (INCY) In A Perilous Reversal
2015-09-02,Incyte Announces Global License Agreement With Jiangsu Hengrui Medicine For SHR-1210, An Investigational Anti-PD-1 Monoclonal Antibody
2015-09-01,Incyte To Present At Upcoming Investor Conferences
2015-08-21,Incyte Named 7th Most Innovative Company In The World By Forbes Magazine
2015-08-14,3 Stocks Dragging The Drugs Industry Downward
2015-08-04,Incyte Reports 2015 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs
2015-07-15,Analysts Break Down Impact Of $7.2B Receptos Buyout
2015-07-14,Incyte To Report Second Quarter Financial Results On August 4
2015-07-07,Incyte And Vanderbilt University Medical Center Establish Multi-Year Oncology Research Alliance
2015-07-06,3 Stocks Boosting The Health Care Sector Higher
2015-06-23,Agenus Gets Billion-Dollar Valuation From Analyst Based on Cancer Drug That Doesn't Exist
2015-06-19,Incyte Announces Organizational And Management Changes To Drive Future Global Expansion
2015-06-05,'Mad Money' Lightning Round: Buy Taser, Have Patience With Baxter
2015-06-04,Jim Cramer's 'Mad Money' Recap: 3 Things Frightening the Market Right Now
2015-06-01,Advaxis Announces FDA Clearance Of Investigational New Drug Application For Phase 2 Study Of ADXS-HPV And Incyte's Epacadostat For The Treatment Of HPV-Associated Early Stage Cervical Cancer
2015-05-30,ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival
2015-05-29,3 Health Care Stocks On The Rise
2015-05-28,Put Health Care Stocks on Your Shopping List
2017-03-19,Here's a Look at the 64 Best Performing Stocks Over the Last 4 Months
2017-03-15,After Soaring to $150, Can Incyte Stir Up More Upside?
2017-03-13,Incyte Corporation Stock Rises on Price Target Increase
2017-03-10,Incyte Pops on Continued Gilead Takeout Speculation
2017-03-10,Incyte Likely to Incite Further Gains
2017-03-10,Don't Give the Fed Credit for This Bull: Cramer's 'Mad Money' Recap (Thursday 3/9/17)
2017-03-09,Cramer: Don't Give the Fed Credit
2017-03-02,Incyte's Targeted Therapy And Immuno-oncology Portfolio To Be Featured In 20 Abstracts At The AACR Annual Meeting 2017
2017-02-28,Voices Of MPN Heroes Video
2017-02-27,Cramer: Money's Being Thrown at Almost Everything in the Market
2017-02-27,Cramer: Money's Being Thrown at Almost Everything in the Market
2017-02-24,4 Biotech Stocks on the Move
2017-02-24,Biotech Movers: Cempra Flys High On Phase Three Results
2017-02-23,Incyte Announces Oncology Research Alliance With The Abramson Cancer Center At The University Of Pennsylvania
2017-02-23,Incyte, Skyworks Solutions, Western Digital, Constellation Brands: 'Mad Money' Lightning Round
2017-02-23,What You Should Do if This Market Is Overvalued: Cramer's 'Mad Money' Recap (Wednesday 2/22/17)
2017-02-21,Incyte To Present At Upcoming Investor Conferences
2017-02-15,Additional Results From Pivotal RA-BEAM Study Published In New England Journal Of Medicine Show Baricitinib-treated Patients Demonstrated Sustained Improvement In Rheumatoid Arthritis Compared To Adalimumab And Placebo
2017-02-15,Softness in Incyte Should Be Short-Lived, if Our Quants Are Right
2017-02-15,Ratings Changes Today
2017-02-14,Http://www.agenusbio.com
2017-02-14,Incyte Reports 2016 Fourth-Quarter And Year-End Financial Results, Provides 2017 Financial Guidance And Updates On Key Clinical Programs
2017-02-14,5 Things You Must Know Before the Market Opens Tuesday
2017-02-12,Week Ahead: Federal Reserve Officials, Major Economic Data to Drive Market Movement
2017-01-30,Incyte And Calithera Biosciences Announce Global Collaboration To Develop And Commercialize CB-1158, A First-in-class, Small Molecule Arginase Inhibitor
2017-01-24,Incyte To Report Fourth Quarter And Year-End Financial Results
2017-01-10,4 Biotech Names That Could Be M&amp;A Targets
2017-01-09,Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference
2017-01-09,Merck Cancer Drug Test Sends Incyte Shares Higher
2017-01-09,Biotech Stocks Surge Monday Amid Flurry of Deal Activity
2017-01-09,Incyte And Merck To Advance Clinical Development Program Investigating The Combination Of Epacadostat With KEYTRUDA® (pembrolizumab)
2017-01-05,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
2017-01-03,Biotech Should Witness M&amp;A's Return in 2017
2016-12-30,Incyte Announces First Patient Treated In Pivotal Clinical Trial Program For Ruxolitinib (Jakafi®) In Graft-versus-Host Disease
2016-12-21,Incyte And Merus Announce Global Strategic Research Collaboration To Discover And Develop Bispecific Antibodies
2016-12-13,Incyte To Present At Upcoming Investor Conference
2016-12-04,Pooled Analysis Of Five-Year Data From Two Phase 3 Studies Further Supports Overall Survival Advantage Observed In Patients With Myelofibrosis Treated With Jakafi® (ruxolitinib)
2016-11-18,2 Small-Cap Biotech Buyout Targets
2016-11-17,Get Excited About Incyte
2016-11-17,Hey Gilead, Stop Developing Drugs and Start Buying Biotech Companies -- Now!
2016-11-14,Baricitinib Demonstrates Early Response Compared To Placebo And Significant Improvement Compared To Adalimumab In Patient-Reported Outcomes
2016-11-13,Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
2016-11-10,Incyte Becomes #40 Most Shorted Nasdaq 100 Component, Replacing Stericycle
2016-11-08,Gilead Sciences' Next Challenge to Incyte's Myelofibrosis Drug Dominance
2016-11-03,More Than 20 Abstracts Highlighting Data From Incyte's Portfolio Accepted For Presentation At The 58th Annual ASH Meeting
2016-11-02,Why Incyte's Shares Could Soon Hit $100
2016-11-02,Incyte To Present At Upcoming Investor Conference
2016-11-01,Incyte Reports 2016 Third-Quarter Financial Results And Updates Key Clinical Programs
2016-11-01,There's Still Time to Buy These 5 Breakout Trades
2016-10-14,Incyte To Report Third Quarter Financial Results
2016-10-07,Additional Phase 1 Data From ECHO-202 Reinforce Durability Of Response In Patients With Treatment-naive Advanced Or Metastatic Melanoma Treated With Epacadostat In Combination With Keytruda® (pembrolizumab)
2016-09-28,Updated Phase 1 Data Reinforce The Clinical Profile Of Epacadostat In Combination With Keytruda® (Pembrolizumab)
2016-09-27,The New #42 Most Shorted Nasdaq 100 Component: Incyte
2016-09-27,NCCN Guidelines® Recommend Jakafi® (ruxolitinib) For The Treatment Of Myelofibrosis
2016-09-22,New Setback for Sanofi's Lantus Increases Need for M&amp;A
2016-09-08,Incyte Supports Those Affected By Rare Blood Cancers On MPN Awareness Day And Throughout Blood Cancer Awareness Month
2016-09-01,'Mad Money' Lightning Round: I'm Staying With Potash
2016-08-31,Jim Cramer's 'Mad Money' Recap: Oil Regains Control of the Stock Market
2016-08-30,Incyte To Present At Upcoming Investor Conferences
2016-08-25,Forbes Magazine Names Incyte To Its List Of World's Most Innovative Companies For Second Consecutive Year
2016-08-22,Incyte (INCY) Stock Rises on Takeover Speculation After $14 Billion Pfizer, Medivation Deal
2016-08-10,How Will Incyte (INCY) Stock React to Price Target Raise at Barclays?
2016-08-09,Why There Is Upside for Incyte Despite Recent Selloff
2016-08-09,Today's Roof Leaker Stock Is Incyte (INCY)
2016-08-09,Incyte Reports 2016 Second-Quarter Financial Results And Updates Key Clinical Programs
2016-08-03,Insider Trading Alert - CFFI, KERX And INCY Traded By Insiders
2016-08-01,Could a Spin-off of its Hepatitis C Division be in Gilead's Future?
2016-07-27,The New #38 Most Shorted Nasdaq 100 Component: Incyte
2016-07-22,3 Stocks Dragging In The Drugs Industry
2016-07-19,Updated Data For Epacadostat, Incyte's Selective IDO1 Inhibitor, Accepted For Presentation At The ESMO Annual Congress 2016
2016-07-14,Incyte To Report Second Quarter Financial Results
2016-07-13,3 Stocks Pushing The Health Care Sector Lower
2016-07-01,Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-23,FDA Grants Breakthrough Therapy Designation For Incyte's Ruxolitinib (Jakafi®) In Acute Graft-Versus-Host Disease (GVHD)
2016-06-22,Incyte Announces First Patient Treated In ECHO-301 Phase 3 Study
2016-06-10,New Phase 3 Data Show Jakafi® (ruxolitinib) Is Superior To Best Available Therapy In Patients With Polycythemia Vera (PV)
2016-06-06,Five-year Results From Phase 3 Study Of Jakafi® (ruxolitinib) Show Sustained Overall Survival Benefit In Patients With Myelofibrosis (MF)
2016-06-01,Incyte And Moffitt Cancer Center Establish Multi-Year Oncology Research Alliance
2016-05-31,Incyte Announces The Launch Of The Incyte Charitable Giving Foundation
2016-05-31,3 Health Care Stocks Pushing Sector Growth
2016-05-26,Investors Eager for Gilead to Make Big Moves
2016-05-25,Gilead (GILD) Shares Spike After Executive Board Appointment
2016-05-19,Incyte Highlights Jakafi® (ruxolitinib) And Capmatinib Abstracts To Be Presented At The 2016 ASCO And EHA Annual Meetings
2016-05-18,Incyte To Present At Upcoming Investor Conferences
2016-05-09,Incyte Buys European Business Hub From Ariad Pharma
2016-05-09,Incyte First Quarter Financial Results Conference Call And Webcast
2016-05-09,Incyte Reports 2016 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs
2016-05-03,The New #44 Most Shorted Nasdaq 100 Component: Incyte
2016-04-28,Incyte To Present At Upcoming Investor Conferences
2016-04-18,Incyte (INCY) Weak On High Volume
2016-04-15,Incyte Investor Event At AACR 2016 To Highlight Innovative And Diversified Research And Development Portfolio
2016-04-14,Incyte To Report First Quarter Financial Results
2016-04-06,Incyte Acquires Rights From Lilly To Develop And Commercialize Ruxolitinib (Jakafi®) For The Treatment Of Patients With Graft-Versus-Host Disease (GVHD)
2016-03-31,Jim Cramer's 'Mad Money' Recap: Good Riddance to a Roller-Coaster Quarter
2016-03-31,Strong On High Relative Volume: Incyte (INCY)
2016-03-31,Phase 3 Study Findings Demonstrate Treatment With Baricitinib Results In Significant Improvements For Patients With Rheumatoid Arthritis Who Had Inadequate Response To Biologics
2016-03-26,5 Stocks Insiders Love Right Now
2016-03-16,Incyte's Immuno-oncology And Targeted Therapy Portfolio To Be Featured At The AACR Annual Meeting 2016
2016-03-09,BMRN, INCY And ALXN, Pushing Drugs Industry Downward
2016-03-02,5 Stocks Insiders Have Been Scooping Up Lately
2016-02-29,Voices Of MPN Rare Disease Day Video
2016-02-20,Jim Jubak&rsquo;s Four Favorite Stocks for Turbulent Markets
2016-02-20,Jim Jubak’s Four Favorite Stocks for Volatile Times
2016-02-17,Ratings Changes Today
2016-02-16,Incyte To Present At Upcoming Investor Conferences
2016-02-12,Incyte (INCY) Stock Price Target Lowered at Jefferies
2016-02-11,Here's Why Incyte (INCY) Stock is Tanking Today
2016-02-11,Unusual Social Activity Today Around Incyte (INCY)
2016-02-11,Incyte Falls on Jakafi Solid-Tumor Setback
2016-02-11,Incyte Reports 2015 Fourth-Quarter And Year-End Financial Results, Provides 2016 Financial Guidance And Updates Shareholders On Key Clinical Programs
2016-02-11,Incyte Announces Decision To Discontinue JANUS Studies Of Ruxolitinib Plus Capecitabine In Patients With Advanced Or Metastatic Pancreatic Cancer
2016-02-05,Incyte (INCY): Today's Weak On High Volume Stock
2016-01-27,Post-Market Activity Shows Incyte (INCY) Down
2016-01-27,Incyte Announces Decision To Stop Phase 2 Sub-study Of Ruxolitinib Plus Regorafenib In Patients With Metastatic Colorectal Cancer And High CRP
2016-01-25,Strong On High Relative Volume: Incyte (INCY)
2016-01-21,Incyte To Report Fourth Quarter/Year-End Financial Results
2016-01-19,Lilly And Incyte Announce Submission Of New Drug Application To FDA For Oral Once-Daily Baricitinib For Treatment Of Moderate-to-Severe Rheumatoid Arthritis
2016-01-12,Incyte (INCY) Shows Signs Of Being Water-Logged And Getting Wetter
2016-01-12,3 Stocks Pulling The Drugs Industry Downward
2016-01-11,Incyte Presents Significant Progress In Its Development Portfolio
2016-01-11,Incyte And AstraZeneca Announce New Lung Cancer Clinical Trial Collaboration
2016-01-07,Trade-Ideas: Incyte (INCY) Is Today's Weak On High Relative Volume Stock
2016-01-07,Jim Cramer's Top Takeaways: Starbucks, Alphabet, Ulta Salon, Micron, Viacom
2016-01-06,Jim Cramer's 'Mad Money' Recap: Good Things to Remember Amid the Fallout
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-26,Sell These 6 Biotech Stocks Now Before It's Too Late
2015-12-24,4 Great Stock-ing Stuffers for 2016
2015-12-22,NVO, INCY And ILMN, Pushing Drugs Industry Downward
2015-12-14,Incyte To Present At The 34th Annual J. P. Morgan Healthcare Conference
2015-12-05,Two Phase 3 Studies Reinforce Sustained Benefits Of Treatment With Jakafi® (ruxolitinib) In Patients With Myeloproliferative Neoplasms (MPNs)
2015-12-05,Phase 3 RESPONSE-2 Study Of Jakafi® (ruxolitinib) Meets Primary Endpoint
2015-12-01,3 Stocks Dragging The Drugs Industry Downward
2015-11-30,Incyte's Jakafi® (ruxolitinib) To Be Featured In Over 60 Abstracts At ASH Annual Meeting
2015-11-18,Goldman Sees Bluebird Shares Doubling On 'One-Shot' Gene Therapy
2015-11-13,Bearish Bets: Personal Bear Market Continues for Energy Stocks
2015-11-09,3 Drugs Stocks Driving The Industry Higher
2015-11-09,Incyte (INCY) Showing Signs Of A Dead Cat Bounce Today
2015-11-07,Detailed Results Demonstrate Baricitinib Superiority To Adalimumab In Improving Signs And Symptoms Of Rheumatoid Arthritis
2015-11-06,Incyte (INCY) Is Today's Roof Leaker Stock
2015-11-06,Ratings Changes Today
2015-11-04,Retrophin Sinks, Pharma Group Swings Back As Pricing Fight Escalates
2015-11-03,Weak On High Volume: Incyte (INCY)
2015-11-03,Epacadostat In Combination With Pembrolizumab Demonstrates Promising Clinical Activity In Multiple Advanced Cancers
2015-11-03,Incyte Reports 2015 Third-Quarter Financial Results And Updates Shareholders On Key Clinical Programs
2015-10-22,Northwest Bio Bothers British Bestie for Bounteous Bucks
2015-10-16,3 Stocks Dragging The Health Care Sector Downward
2015-10-16,Trade-Ideas: Incyte (INCY) Is Today's "Perilous Reversal" Stock
2015-10-13,Incyte To Report Third Quarter Financial Results
2015-10-13,Incyte And Merck Expand Clinical Collaboration To Include Phase 3 Study Investigating The Combination Of Epacadostat With Keytruda® (pembrolizumab) As First-line Treatment For Advanced Melanoma
2015-10-05,Incyte (INCY) Highlighted As Today's Perilous Reversal Stock
2015-10-02,Data At SITC Annual Meeting To Highlight Progress Of Incyte's Immuno-oncology Portfolio
2015-09-30,10 Best Nasdaq Biotech Stocks in the Third Quarter
2015-09-30,Strong On High Relative Volume: Incyte (INCY)
2015-09-29,Market News: Under Armour, OvaScience, Incyte Corporation
2015-09-29,Incyte (INCY) Stock Climbs on Positive Arthritis Test Results
2015-09-29,Eli Lilly (LLY) Stock Climbs on Positive Arthritis Drug Test Results
2015-09-29,Incyte (INCY) Weak On High Volume
2015-09-28,Trade-Ideas: Incyte (INCY) Is Today's "Roof Leaker" Stock
2015-09-16,Insider Trading Alert - RP, LAYN And INCY Traded By Insiders
2015-09-15,Incyte To Present At The Leerink Partners Inaugural Immuno-Oncology Roundtable Conference
2015-09-14,Incyte (INCY) In A Perilous Reversal
2015-09-03,Incyte (INCY) In A Perilous Reversal
2015-09-02,Incyte Announces Global License Agreement With Jiangsu Hengrui Medicine For SHR-1210, An Investigational Anti-PD-1 Monoclonal Antibody
2015-09-01,Incyte To Present At Upcoming Investor Conferences
2015-08-21,Incyte Named 7th Most Innovative Company In The World By Forbes Magazine
2015-08-14,3 Stocks Dragging The Drugs Industry Downward
2015-08-04,Incyte Reports 2015 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs
2015-07-15,Analysts Break Down Impact Of $7.2B Receptos Buyout
2015-07-14,Incyte To Report Second Quarter Financial Results On August 4
2015-07-07,Incyte And Vanderbilt University Medical Center Establish Multi-Year Oncology Research Alliance
2015-07-06,3 Stocks Boosting The Health Care Sector Higher
2015-06-23,Agenus Gets Billion-Dollar Valuation From Analyst Based on Cancer Drug That Doesn't Exist
2015-06-19,Incyte Announces Organizational And Management Changes To Drive Future Global Expansion
2015-06-05,'Mad Money' Lightning Round: Buy Taser, Have Patience With Baxter
2015-06-04,Jim Cramer's 'Mad Money' Recap: 3 Things Frightening the Market Right Now
2015-06-01,Advaxis Announces FDA Clearance Of Investigational New Drug Application For Phase 2 Study Of ADXS-HPV And Incyte's Epacadostat For The Treatment Of HPV-Associated Early Stage Cervical Cancer
2015-05-30,ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival
2015-05-29,3 Health Care Stocks On The Rise
2015-05-28,Put Health Care Stocks on Your Shopping List
